Pretympanoplasty Assessment of Patency and Mucociliary Function of Eustachian Tube
NCT05229380 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-02-08
Summary
The eustachian tube (ET) performs three primary functions: pressure equalisation between the nasopharyms and middle ear: clearance of mucus from the middle ear, and prevention of sound or fluid reflux from the nasopharynx(1) .In individuals suffering from custachian tube dysunction (ETD), the tube opening may be obstructed(2) resulting in the typical complaints of ear fullness, muffled hearing, or tinnitus(3). Less frequently, the ET may be permanently patulous, resulting in the symptoms of aural pressure or autophony (4). Adequate Eustachian tube function (ETF) is necessary for successful middle ear surgery. Studies of eustachian tube patency have been studied by the Politzer, Valsalva, and Toynbee maneuvers. In other cases it has been accomplished by testing air transport through the eustachian tube by tympanometry, sonotubometry, and air pressure equalization technique. However, these methods do not evaluate the drainage function (5). Saccharin is a nonnutritive sweetener. It has property of being inert to respiratory epithelium that is it does not hamper physiological mucus clearance of sino-nasal mucosa. It can be used to assess mucocilliary function of nasal mucosa, without itself hampering it. The saccharin test seems to provide adequate information of the mucociliary function and patency of the ET (6) . Methylene blue is a chemical compound. It can be used to check patency of (ET). The dye, because of its liquid form, gravitates through the ET to the nasopharynx. So the objective of the dye is to establish the anatomical presence or absence of tube patency.
Conditions
- Eustachian Tube Dysfunction
Interventions
- DRUG
-
Saccharin test
Saccharin is a nonnutritive sweetener. It has property of being inert to respiratory epithelium that is it does not hamper physiological mucus clearance of sino-nasal mucosa. Methylene blue is a chemical compound. It can be used to check patency of (ET). The dye, because of its liquid form, gravitates through the ET to the nasopharynx.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-28
- Primary Completion
- 2022-12-31
- Completion
- 2023-01-31
More Related Trials
-
Feasibility of Balloon Dilation of the Eustachian Tubes Under Local Anesthesia
NCT04055714 ·Status: UNKNOWN ·Phase: NA
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
NCT00694421 ·Status: COMPLETED
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c
NCT00422851 ·Status: COMPLETED
-
Posterior vs. Anterior Tympanostomy Tube Placement
NCT06191562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
XprESS Eustachian Tube Dilation Study
NCT02391584 ·Status: COMPLETED ·Phase: NA
-
Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1
NCT01925482 ·Status: COMPLETED ·Phase: PHASE1
-
SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
NCT04404036 ·Status: COMPLETED ·Phase: NA
-
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
NCT04462198 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study of the Tympanostomy Tube Delivery System
NCT00939796 ·Status: COMPLETED ·Phase: NA
-
Novel Imaging of the Eustachian Tube; Patient Study
NCT02282540 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Transcanal Tympanoplasty With Attico-antrostomy Versus Endoscopic-assisted Canal Wall up Mastoidectomy in Management of Localized Cholesteatoma: A Randomized Clinical Trial
NCT04959539 ·Status: COMPLETED ·Phase: NA
-
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
NCT04766853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss
NCT05455398 ·Status: UNKNOWN ·Phase: NA
-
A Non-invasive Device to Remove Fluid From the Middle Ear
NCT03978195 ·Status: UNKNOWN ·Phase: NA
-
Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
NCT01661777 ·Status: WITHDRAWN ·Phase: NA
-
OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
NCT01755286 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration
NCT02350998 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tympanostomy Tube Delivery System
NCT01202578 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
NCT01949142 ·Status: COMPLETED ·Phase: PHASE3
-
Singapore Tympanostomy Tube Delivery System Study
NCT01046877 ·Status: COMPLETED ·Phase: NA
-
Hummingbird TTS Ear Tube Delivery Study
NCT02165384 ·Status: COMPLETED ·Phase: NA
-
Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion
NCT02150044 ·Status: COMPLETED ·Phase: NA
-
Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT00279916 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis
NCT00525551 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
NCT05133258 ·Status: COMPLETED